CirrhosisNCT01882855
Effect of Music on Attention and Prospective Memory in Hepatic Encephalopathy
An observational study of Cirrhosis and Hepatic Encephalopathy, run by NYU Langone Health at 1 site in United States.
Trial summary
Hepatic encephalopathy (HE) is a potentially reversible, metabolically caused complication of acute or chronic liver diseases such as cirrhosis. Due to the diseased liver's inability to remove toxins such as ammonia, which is produced in the gastrointestinal tract, the ammonia accumulates in the brain and causes… Read more about this study
- Who is it for?
- Ages 18 to 70 years
- Conditions the study is for
- Cirrhosis, Hepatic Encephalopathy
- How many people
- 0 participants
- Where
- 1 siteUnited States
- Study dates
- Dec 2012to Mar 2016
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 70 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: At least fifty subjects will be included in this study, including screening failures. There will be an equitable inclusion of both men and women in this study. Subjects must be between the ages of 18 and 70 to participate in this study. There is no restriction on race or ethnicity in this study. An effort will be made to recruit a diverse sample of participants.
Who may be able to join
- Ambulatory patient with cirrhosis
- Able to provide informed consent
Who cannot join
- History of alcohol abuse within six months
- Active gastrointestinal bleeding
- Unable to provide informed consent
Trial locations and contacts
1 site in 1 country.
About this study
Hepatic encephalopathy (HE) is a potentially reversible, metabolically caused complication of acute or chronic liver diseases such as cirrhosis. Due to the diseased liver's inability to remove toxins such as ammonia, which is produced in the gastrointestinal tract, the ammonia accumulates in the brain and causes forgetfulness, confusion, disorientation, concentration and memory problems, changes in mood, decreased alertness and responsiveness, changes in sleep habits, muscle tremors and stiffness, speech impairments, uncontrollable movements, agitation.
This study will examine music as a possible external factor that could contribute to impairment in attention and progressive memory in cirrhotic patients while driving. Sustaining attention is important for learning and remembering new information, for e.g. keeping the car within lane and paying attention to cyclists and pedestrians. Prospective memory is the ability to remember to perform previously intended tasks at the appropriate time or occasion, for instance remembering the correct exit while driving on the highway. Impairment in any of these areas may result in serious consequences for patient with cirrhosis. There is evidence that some subsets of cirrhotic patients have a diminished ability to drive and significantly more motor vehicle crashes and traffic violations. In these patients, listening to music while driving may further jeopardize their driving ability, which in turn may lead to reduced quality of life and increased medical costs (from motor vehicle accidents).
This is a cross-sectional study designed to determine if there is any effect of listening to music on attention and prospective memory in patients with cirrhosis. For these purposes, subjects will be asked to come for one study visit, which will last approximately 2 hours. During this visit, subjects will undergo a series of screening procedures (consent, assignment of subject identification number, demographics, medical history, physical examination, vitals, height, weight, and eligibility assessment). If they are found eligible, subjects will undergo several neuropsychological assessments to measure any effect of music on attention and prospective memory. These assessments include including Number Connection Test (NCT), Digit Symbol Test (DST), Cambridge Prospective Memory Test (CAMPROMPT) and Inhibitory Control Test (ICT).
Read the detailed description
Cirrhosis occurs when scar tissue replaces healthy liver tissue, partially blocking blood flow and preventing the liver's ability to control infections, removes bacteria and toxins from the blood, and to produce proteins to regulate blood clotting and bile to absorb fats and fat-soluble vitamins. With an estimated prevalence between five and ten percent, cirrhosis is the twelfth leading cause of death by disease, leading to 27,000 deaths per year. Heavy alcohol consumption and hepatotropic viruses (hepatitis B and C) are the major contributors to this disease's prevalence (NDDIC, 2003).
Hepatic encephalopathy (HE) is a potentially reversible, metabolically caused complication of acute or chronic liver diseases such as cirrhosis, which is characterized by neuropsychiatric abnormalities. Nearly 70% of cirrhotic patients experience mild levels of HE and approximately 30% of end-stage patients experience significant HE symptoms, many approaching coma (Mullen et al., 1999). Although the pathophysiology of HE is not yet clearly understood, the accumulation of ammonia in the brain due to the liver's inability to remove toxins (including ammonia) is thought to play a key role in the pathogenesis of HE. Other factors, which are not mutually exclusive, include increased GABA-ergic tone, selective alterations of the blood-brain barrier permeability and changes in neurotransmitter systems. The broad spectrum of symptoms in HE include forgetfulness, confusion, disorientation, concentration and memory problems, changes in mood, decreased alertness and responsiveness, changes in sleep habits, muscle tremors and stiffness, speech impairments, uncontrollable movements, agitation (Ferenci et al., 2002).
The diagnosis of HE is essentially based on clinical history and laboratory findings such as elevated ammonia levels. Additionally, specialized psychometric tests such as the number connection test (NCT), Digit Symbol Test (DST) and Psychometric Hepatic Encephalopathy Score (PHES) have been used in quantifying the minor deficits that may be present in patients with early HE.
Minimal hepatic encephalopathy (MHE) is a category of early HE without any overt neuropsychiatric symptoms but with subtle cognitive deficits (Ferenci et al., 1998). It is a common complication of cirrhosis and has been reported in 20% to 74% of patients (Dhiman et al., 2010), depending on the test used for diagnosis. It results in deficits in specific cognitive domains such as attention, vigilance, response inhibition, executive function and prospective memory. These deficits are often not apparent from a routine neurological exam or MMSE but can be detected on psychometric testing. The prompt identification and treatment of MHE are essential because MHE predicts progression to overt HE and impairs the capacity to drive which can have a significant impact on patients' quality of life (Romero-Gomez et al., 2001; Wein et al, 2004) .
Treatment of HE with or without liver transplantation has been shown to reverse the cognitive deficits and improve quality of life (Prasad et al., 2007; Sidhu et al., 2011). Although the PHES and NCT are the gold standard for diagnosing MHE, their utility is limited due to expensive copyright, a need for trained psychologists and the lack of reimbursements from insurance companies. A simpler test would therefore be beneficial to internists who could easily implement it in the clinic setting.
The inhibitory control task (ICT) is a computerized psychometric test that has been introduced recently as a diagnostic tool for MHE. It measures the ability to sustain attention and to inhibit responses to relevant stimuli, 2 basic cognitive domains that are impaired in MHE. During the ICT, the patient is presented with a continuous stream of letters at 500-ms intervals and interspersed within these letters are the letters X and Y. Subjects are instructed to only respond when the letters "X" and "Y" are alternated (called targets), independent of the letters between them. In contrast, patients are instructed to refrain from responding, i.e. inhibit their response, when "X" and "Y" are not alternating (called lures). Higher rates of target response, lower rates of lure response and shorter reaction times indicate better attention and response inhibition. One study by Bajaj et al. (2008) showed the ICT to be a reliable test with 87% sensitivity for the diagnosis of MHE, with MHE patients having higher ICT lures and lower targets compared to patients without MHE.
Patients with MHE have deficits in attention and prospective memory which are cognitive domains that are important to activities such as driving. Sustaining attention is important for learning and remembering new information, for e.g. keeping the car within the lane while driving and paying attention to pedestrians and cyclists. Prospective memory involves both working memory (to formulate, initiate, and modify plans of action) and retrospective memory (to recall what needs to be done at a particular time or in response to an external cue), for instance, remembering the correct exit while driving on the highway. The act of driving requires the ability to sustain attention and utilize prospective memory under stressful conditions. Impairment in any of these areas may result in serious consequences for patient with chronic liver disease, such as cirrhosis. Indeed, some studies of cirrhotic patients have shown that those with MHE have a diminished ability to drive and significantly more motor vehicle crashes and traffic violations than those without MHE (Bajaj et al., 2007, 2009). The reasons behind this are thought to be not only the obvious cognitive deficits, but also a greater tendency to fatigue at the wheel and poor insight into the cognitive deficiencies (Kircheis et al., 2009). In fact, driving simulator tests and questionnaire surveys have shown that patients with MHE who have been diagnosed using the ICT have impaired navigational skills and significantly higher crash rates (Bajaj et al., 2008, 2009).
In addition to the potential value of the ICT in detecting MHE, the test may be useful in uncovering temporary insults to attention and working memory that may arise in the presence of external stimuli such as music. Listening to music while driving is a pervasive practice and the relationship between background music and driving performance has been studied in the past (Unal et al., 2012; van der Zwaag et al., 2012). However these studies did not specifically address patients with cirrhosis, who are a population at higher risk of traffic accidents. The hypothesis of our study are (1) cirrhotic patients with MHE are expected to have lower ICT scores than patients without MHE and (2) these deficits are expected to worsen in the presence of music, suggesting music as a possible factor that could contribute to impaired attention and working memory, and hence impaired driving ability in cirrhotic patients. To this end, various types of music, including classical and heavy metal, will be used as a means of distracting cirrhotic patients while they are administered the ICT, to determine if there is any effect of listening to music on ICT scores. In addition to the ICT, the Digit Symbol Test, Number Connection Test, Cambridge Prospective Memory Test (CAMPROMPT), Stroop test, Fisk Fatigue Impact Scale and Epworth Sleepiness Scale will also be administered to quantify the degree of HE. While the use of ICT may not be appropriate for definitively predicting driving fitness, it may be valuable in uncovering deficits in attention and memory that arise while listening to music, which may ultimately aid in the counseling and education of patients regarding safe driving practices.
- Conditions
- Cirrhosis, Hepatic Encephalopathy
- Medical subject headings
- Fibrosis, Hepatic Encephalopathy
What is being measured
The primary outcome is the main question the study is designed to answer.
Lure Response Inhibition on Inhibitory Control Test
Measured: The ICT will be administered with and without background music during a single visit.
Secondary outcomes (1)
Target Responses on Inhibitory Control Test
Measured: The ICT will be administered with and without background music during a single visit.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Jun 2013 (estimated)
- Study startDec 2012
- Primary completionMar 2016
- Study completionMar 2016
Why it stopped: Dr. Sigal no longer with NYUMC
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for CirrhosisStudies of the same condition, open and under way.
- More trials run by NYU Langone HealthThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- NYU Langone Health
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Samuel Sigal, MD, Principal investigator, NYU Langone Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01882855
- Sponsor's protocol ID
- S12-03729
- Status last verified
- Mar 2016
- First submitted
- 1 May 2013
- Last updated
- 11 Mar 2016
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 11 Mar 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Music on Attention and Prospective Memory in Hepatic Encephalopathy
- ClinicalTrials.gov ID
- NCT01882855
- Acronym / sponsor ID
- S12-03729
- Conditions
- Cirrhosis, Hepatic Encephalopathy
- Study type
- Observational
- Recruitment status
- WithdrawnReason stopped: Dr. Sigal no longer with NYUMC
- Enrolment
- 0 participants (actual)
- Lead sponsor
- NYU Langone HealthUniversity, hospital or other
- Study start
- Dec 2012
- Primary completion
- Mar 2016 (actual)
- Study completion
- Mar 2016 (actual)
- First posted
- 20 Jun 2013 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Hepatic encephalopathy (HE) is a potentially reversible, metabolically caused complication of acute or chronic liver diseases such as cirrhosis. Due to the diseased liver's inability to remove toxins such as ammonia, which is produced in the gastrointestinal tract, the ammonia accumulates in the brain and causes forgetfulness, confusion, disorientation, concentration and memory problems, changes in mood, decreased alertness and responsiveness, changes in sleep habits, muscle tremors and stiffness, speech impairments, uncontrollable movements, agitation.
This study will examine music as a possible external factor that could contribute to impairment in attention and progressive memory in cirrhotic patients while driving. Sustaining attention is important for learning and remembering new information, for e.g. keeping the car within lane and paying attention to cyclists and pedestrians. Prospective memory is the ability to remember to perform previously intended tasks at the appropriate time or occasion, for instance remembering the correct exit while driving on the highway. Impairment in any of these areas may result in serious consequences for patient with cirrhosis. There is evidence that some subsets of cirrhotic patients have a diminished ability to drive and significantly more motor vehicle crashes and traffic violations. In these patients, listening to music while driving may further jeopardize their driving ability, which in turn may lead to reduced quality of life and increased medical costs (from motor vehicle accidents).
This is a cross-sectional study designed to determine if there is any effect of listening to music on attention and prospective memory in patients with cirrhosis. For these purposes, subjects will be asked to come for one study visit, which will last approximately 2 hours. During this visit, subjects will undergo a series of screening procedures (consent, assignment of subject identification number, demographics, medical history, physical examination, vitals, height, weight, and eligibility assessment). If they are found eligible, subjects will undergo several neuropsychological assessments to measure any effect of music on attention and prospective memory. These assessments include including Number Connection Test (NCT), Digit Symbol Test (DST), Cambridge Prospective Memory Test (CAMPROMPT) and Inhibitory Control Test (ICT).
Detailed description
Cirrhosis occurs when scar tissue replaces healthy liver tissue, partially blocking blood flow and preventing the liver's ability to control infections, removes bacteria and toxins from the blood, and to produce proteins to regulate blood clotting and bile to absorb fats and fat-soluble vitamins. With an estimated prevalence between five and ten percent, cirrhosis is the twelfth leading cause of death by disease, leading to 27,000 deaths per year. Heavy alcohol consumption and hepatotropic viruses (hepatitis B and C) are the major contributors to this disease's prevalence (NDDIC, 2003).
Hepatic encephalopathy (HE) is a potentially reversible, metabolically caused complication of acute or chronic liver diseases such as cirrhosis, which is characterized by neuropsychiatric abnormalities. Nearly 70% of cirrhotic patients experience mild levels of HE and approximately 30% of end-stage patients experience significant HE symptoms, many approaching coma (Mullen et al., 1999). Although the pathophysiology of HE is not yet clearly understood, the accumulation of ammonia in the brain due to the liver's inability to remove toxins (including ammonia) is thought to play a key role in the pathogenesis of HE. Other factors, which are not mutually exclusive, include increased GABA-ergic tone, selective alterations of the blood-brain barrier permeability and changes in neurotransmitter systems. The broad spectrum of symptoms in HE include forgetfulness, confusion, disorientation, concentration and memory problems, changes in mood, decreased alertness and responsiveness, changes in sleep habits, muscle tremors and stiffness, speech impairments, uncontrollable movements, agitation (Ferenci et al., 2002).
The diagnosis of HE is essentially based on clinical history and laboratory findings such as elevated ammonia levels. Additionally, specialized psychometric tests such as the number connection test (NCT), Digit Symbol Test (DST) and Psychometric Hepatic Encephalopathy Score (PHES) have been used in quantifying the minor deficits that may be present in patients with early HE.
Minimal hepatic encephalopathy (MHE) is a category of early HE without any overt neuropsychiatric symptoms but with subtle cognitive deficits (Ferenci et al., 1998). It is a common complication of cirrhosis and has been reported in 20% to 74% of patients (Dhiman et al., 2010), depending on the test used for diagnosis. It results in deficits in specific cognitive domains such as attention, vigilance, response inhibition, executive function and prospective memory. These deficits are often not apparent from a routine neurological exam or MMSE but can be detected on psychometric testing. The prompt identification and treatment of MHE are essential because MHE predicts progression to overt HE and impairs the capacity to drive which can have a significant impact on patients' quality of life (Romero-Gomez et al., 2001; Wein et al, 2004) .
Treatment of HE with or without liver transplantation has been shown to reverse the cognitive deficits and improve quality of life (Prasad et al., 2007; Sidhu et al., 2011). Although the PHES and NCT are the gold standard for diagnosing MHE, their utility is limited due to expensive copyright, a need for trained psychologists and the lack of reimbursements from insurance companies. A simpler test would therefore be beneficial to internists who could easily implement it in the clinic setting.
The inhibitory control task (ICT) is a computerized psychometric test that has been introduced recently as a diagnostic tool for MHE. It measures the ability to sustain attention and to inhibit responses to relevant stimuli, 2 basic cognitive domains that are impaired in MHE. During the ICT, the patient is presented with a continuous stream of letters at 500-ms intervals and interspersed within these letters are the letters X and Y. Subjects are instructed to only respond when the letters "X" and "Y" are alternated (called targets), independent of the letters between them. In contrast, patients are instructed to refrain from responding, i.e. inhibit their response, when "X" and "Y" are not alternating (called lures). Higher rates of target response, lower rates of lure response and shorter reaction times indicate better attention and response inhibition. One study by Bajaj et al. (2008) showed the ICT to be a reliable test with 87% sensitivity for the diagnosis of MHE, with MHE patients having higher ICT lures and lower targets compared to patients without MHE.
Patients with MHE have deficits in attention and prospective memory which are cognitive domains that are important to activities such as driving. Sustaining attention is important for learning and remembering new information, for e.g. keeping the car within the lane while driving and paying attention to pedestrians and cyclists. Prospective memory involves both working memory (to formulate, initiate, and modify plans of action) and retrospective memory (to recall what needs to be done at a particular time or in response to an external cue), for instance, remembering the correct exit while driving on the highway. The act of driving requires the ability to sustain attention and utilize prospective memory under stressful conditions. Impairment in any of these areas may result in serious consequences for patient with chronic liver disease, such as cirrhosis. Indeed, some studies of cirrhotic patients have shown that those with MHE have a diminished ability to drive and significantly more motor vehicle crashes and traffic violations than those without MHE (Bajaj et al., 2007, 2009). The reasons behind this are thought to be not only the obvious cognitive deficits, but also a greater tendency to fatigue at the wheel and poor insight into the cognitive deficiencies (Kircheis et al., 2009). In fact, driving simulator tests and questionnaire surveys have shown that patients with MHE who have been diagnosed using the ICT have impaired navigational skills and significantly higher crash rates (Bajaj et al., 2008, 2009).
In addition to the potential value of the ICT in detecting MHE, the test may be useful in uncovering temporary insults to attention and working memory that may arise in the presence of external stimuli such as music. Listening to music while driving is a pervasive practice and the relationship between background music and driving performance has been studied in the past (Unal et al., 2012; van der Zwaag et al., 2012). However these studies did not specifically address patients with cirrhosis, who are a population at higher risk of traffic accidents. The hypothesis of our study are (1) cirrhotic patients with MHE are expected to have lower ICT scores than patients without MHE and (2) these deficits are expected to worsen in the presence of music, suggesting music as a possible factor that could contribute to impaired attention and working memory, and hence impaired driving ability in cirrhotic patients. To this end, various types of music, including classical and heavy metal, will be used as a means of distracting cirrhotic patients while they are administered the ICT, to determine if there is any effect of listening to music on ICT scores. In addition to the ICT, the Digit Symbol Test, Number Connection Test, Cambridge Prospective Memory Test (CAMPROMPT), Stroop test, Fisk Fatigue Impact Scale and Epworth Sleepiness Scale will also be administered to quantify the degree of HE. While the use of ICT may not be appropriate for definitively predicting driving fitness, it may be valuable in uncovering deficits in attention and memory that arise while listening to music, which may ultimately aid in the counseling and education of patients regarding safe driving practices.
Study design
- Observational model
- Case only
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 18 to 70 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- At least fifty subjects will be included in this study, including screening failures. There will be an equitable inclusion of both men and women in this study. Subjects must be between the ages of 18 and 70 to participate in this study. There is no restriction on race or ethnicity in this study. An effort will be made to recruit a diverse sample of participants.
Key inclusion criteria (2 listed)
- Ambulatory patient with cirrhosis
- Able to provide informed consent
Key exclusion criteria (3 listed)
- History of alcohol abuse within six months
- Active gastrointestinal bleeding
- Unable to provide informed consent
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Lure Response Inhibition on Inhibitory Control Test
Time frame: The ICT will be administered with and without background music during a single visit.
1 secondary outcome
Target Responses on Inhibitory Control Test
Time frame: The ICT will be administered with and without background music during a single visit.
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 Mar 2016.
Related trials for Cirrhosis
RecruitingObservational study
Effectiveness and Clinical Outcomes of Long-term Bulevirtide Monotherapy in Patients With HDV-related Compensated Cirrhosis
Hepatitis D
Recruiting
Optimal Treatment Strategy for Spontaneous Bacterial Peritonitis
Spontaneous Bacterial Peritonitis, Paracentesis
RecruitingObservational study
The Value of Spleen Thickness and Spleen Diameter for Gastroesophageal Varices Diagnosis in Compensated Cirrhosis
Liver Cirrhosis, Gastroesophageal Varices
Recruiting
CirrhosisRx CDS System
Cirrhosis, Decision Support Systems, Clinical
RecruitingPhase 3
Trial to Evaluate ALN-CIDEB in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Metabolic Dysfunction-Associated Steatotic Liver Disease, MASLD
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Samuel Sigal, MD principal investigator
NYU Langone Medical Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cirrhosis and Hepatic Encephalopathy, run by NYU Langone Health at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 11 Mar 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Lure Response Inhibition on Inhibitory Control Test (time frame: The ICT will be administered with and without background music during a single visit.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Mar 2016.